Hopkinson Craig C.

EVP R&D, Chief Medical Officer at ALKS

Sold, on record
$24.7M
Dollars the filings state
Form 4 sales
25
Latest Sep 1, 2026
Form 144 notices
15
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ALKSAlkermes plc.EVP R&D, Chief Medical Officer

Sales by reason

12
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice ALKSNotice
    Feb 2, 2026 2026

    Filed to sell 9,000 shares ($305k)

    Hopkinson Craig C., Officer

    10b5-1 plan1x usual sizeFiling

  2. 2 Form 4 sale ALKSRoutine
    Mar 2, 2026 +28 days

    Sold 9,000 shares at $29.72 ($267k)

    Hopkinson Craig C., EVP R&D, Chief Medical Officer

    10b5-1 planSold 9.1% of holdings ($2.9M position)89,389 shares left1x usual sizeFiling

  3. 3 Form 4 sale ALKSRoutine
    Apr 1, 2026 +30 days

    Sold 9,000 shares at $35.51 ($320k)

    Hopkinson Craig C., EVP R&D, Chief Medical Officer

    10b5-1 planSold 9.5% of holdings ($3.4M position)85,389 shares left1x usual sizeFiling

  4. 4 Form 4 sale ALKSRoutine
    May 1, 2026 +30 days

    Sold 9,000 shares at $33.40 ($301k)

    Hopkinson Craig C., EVP R&D, Chief Medical Officer

    10b5-1 planSold 10% of holdings ($3M position)81,389 shares left1x usual sizeFiling

  5. 5 Form 4 sale ALKSRoutine
    Jun 1, 2026 +31 days

    Sold 9,000 shares at $41.67 ($375k)

    Hopkinson Craig C., EVP R&D, Chief Medical Officer

    10b5-1 planSold 10.4% of holdings ($3.6M position)77,389 shares left1x usual sizeFiling

  6. 6 Form 4 sale ALKSRoutine
    Jul 1, 2026 +30 days

    Sold 9,000 shares at $51.51 ($464k)

    Hopkinson Craig C., EVP R&D, Chief Medical Officer

    10b5-1 planSold 10.9% of holdings ($4.2M position)73,389 shares left1x usual sizeFiling

  7. 7 Form 4 sale ALKSRoutine
    Aug 3, 2026 +33 days

    Sold 9,000 shares at $48.58 ($437k)

    Hopkinson Craig C., EVP R&D, Chief Medical Officer

    10b5-1 planSold 11.5% of holdings ($3.8M position)69,389 shares left1x usual sizeFiling

  8. 8 Form 4 sale ALKSRoutine
    Sep 1, 2026 +29 days

    Sold 9,000 shares at $46.99 ($423k)

    Hopkinson Craig C., EVP R&D, Chief Medical Officer

    10b5-1 planSold 12.1% of holdings ($3.5M position)65,389 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (40)

Form 144 notices and Form 4 sales by Hopkinson Craig C.
Source
Sep 1, 2026Sep 1, 2026ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,000$423k12.1%RoutineSEC
Aug 3, 2026Aug 3, 2026ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,000$437k11.5%RoutineSEC
Jul 1, 2026Jul 1, 2026ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,000$464k10.9%RoutineSEC
Jun 1, 2026Jun 1, 2026ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,000$375k10.4%RoutineSEC
May 1, 2026May 1, 2026ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,000$301k10.0%RoutineSEC
Apr 1, 2026Apr 1, 2026ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,000$320k9.5%RoutineSEC
Mar 2, 2026Mar 4, 2026ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,000$267k9.1%RoutineSEC
Feb 2, 2026Feb 2, 2026ALKSOfficerForm 144 notice9,000$305kNoticeSEC
Feb 2, 2026Feb 2, 2026ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,000$305k13.5%RoutineSEC
Jan 8, 2026Jan 8, 2026ALKSOfficerForm 144 notice5,000$150kNoticeSEC
Jan 8, 2026Jan 8, 2026ALKSEVP R&D, Chief Medical OfficerForm 4 sale5,000$150k7.5%RoutineSEC
Jan 2, 2026Jan 2, 2026ALKSOfficerForm 144 notice4,000$112kNoticeSEC
Jan 2, 2026Jan 2, 2026ALKSEVP R&D, Chief Medical OfficerForm 4 sale4,000$112k6.1%RoutineSEC
Dec 3, 2025Dec 5, 2025ALKSEVP R&D, Chief Medical OfficerForm 4 sale3,748$112k5.4%RoutineSEC
Dec 3, 2025Dec 3, 2025ALKSOfficerForm 144 notice3,748$112kNoticeSEC
Dec 1, 2025Dec 1, 2025ALKSOfficerForm 144 notice4,000$117kNoticeSEC
Dec 1, 2025Dec 1, 2025ALKSEVP R&D, Chief Medical OfficerForm 4 sale4,000$117k5.7%RoutineSEC
Nov 3, 2025Nov 3, 2025ALKSOfficerForm 144 notice9,000$273kNoticeSEC
Nov 3, 2025Nov 3, 2025ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,000$273k11.4%RoutineSEC
Oct 15, 2025Oct 15, 2025ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,000$284k10.9%RoutineSEC
Oct 15, 2025Oct 15, 2025ALKSOfficerForm 144 notice9,000$284kNoticeSEC
Feb 13, 2025Feb 14, 2025ALKSEVP R&D, Chief Medical OfficerForm 4 sale349,340$11.8M85.8%UnusualSEC
Feb 13, 2025Feb 13, 2025ALKSOfficerForm 144 notice144,419$5.1MNoticeSEC
Feb 12, 2025Feb 12, 2025ALKSOfficerForm 144 notice204,921$6.7MNoticeSEC
Jan 30, 2025Jan 31, 2025ALKSEVP R&D, Chief Medical OfficerForm 4 sale100,918$3.2M69.5%UnusualSEC
Jan 30, 2025Jan 30, 2025ALKSOfficerForm 144 notice100,918$3.2MNoticeSEC
Dec 9, 2024Dec 9, 2024ALKSEVP R&D, Chief Medical OfficerForm 4 sale61,151$2M56.2%RoutineSEC
Dec 9, 2024Dec 9, 2024ALKSOfficerForm 144 notice61,151$2MNoticeSEC
Dec 5, 2024Dec 5, 2024ALKSEVP R&D, Chief Medical OfficerForm 4 sale9,221$290k13.4%RoutineSEC
Dec 5, 2024Dec 5, 2024ALKSOfficerForm 144 notice9,221$290kNoticeSEC
Dec 4, 2024Dec 4, 2024ALKSEVP R&D, Chief Medical OfficerForm 4 sale14,349$442k17.2%RoutineSEC
Dec 4, 2024Dec 4, 2024ALKSOfficerForm 144 notice14,349$442kNoticeSEC
Nov 11, 2024Nov 12, 2024ALKSOfficerForm 144 notice58,996$1.8MNoticeSEC
Nov 11, 2024Nov 12, 2024ALKSEVP R&D, Chief Medical OfficerForm 4 sale58,996$1.8M41.5%RoutineSEC
Nov 6, 2024Nov 6, 2024ALKSOfficerForm 144 notice10,471$309kNoticeSEC
Nov 6, 2024Nov 6, 2024ALKSEVP R&D, Chief Medical OfficerForm 4 sale10,471$309k9.5%RoutineSEC
Feb 23, 2022Feb 24, 2022ALKSEVP R&D, Chief Medical OfficerForm 4 sale11,983$297k40.0%UnusualSEC
Feb 18, 2022Feb 23, 2022ALKSEVP R&D, Chief Medical OfficerForm 4 sale2,306$58k19.5%Plan not statedSEC
Jun 9, 2021Jun 11, 2021ALKSEVP R&D, Chief Medical OfficerForm 4 sale882$22k100.0%UnusualSEC
Apr 15, 2021Apr 16, 2021ALKSEVP R&D, Chief Medical OfficerForm 4 sale28,920$570k100.0%UnusualSEC